Oncorus to Present at the H.C. Wainwright BioConnect Virtual Conference
03 January 2022 - 11:00PM
Oncorus, Inc. (NASDAQ: ONCR), a viral immunotherapies company
focused on driving innovation to transform outcomes for cancer
patients, today announced that President and Chief Executive
Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will participate in a
fireside chat at the H.C. Wainwright BioConnect Conference.
The fireside chat will be available for on-demand viewing
beginning Monday, January 10, 2022 at 7:00am ET under the Investors
& Media section of Oncorus’ website
at https://investors.oncorus.com/. A replay of the
presentation will be archived on Oncorus’ site for 90 days
following the event.
About OncorusAt Oncorus, we are focused on
driving innovation to deliver next-generation viral immunotherapies
to transform outcomes for cancer patients. We are advancing a
portfolio of intratumorally (iTu) and intravenously (IV)
administered viral immunotherapies for multiple indications with
significant unmet need based on our oncolytic Herpes Simplex Virus
(HSV) Platform and Synthetic viral RNA (vRNA) Immunotherapy
Platform.
Designed to deliver next-generation viral immunotherapy impact,
our HSV Platform improves upon key characteristics of this
therapeutic class to enhance systemic activity. Our lead HSV
program, ONCR-177, is designed to be directly administered into a
tumor, resulting in high local concentrations of the therapeutic
agent and its five encoded transgenes, as well as low systemic
exposure to the therapy, which could limit systemic toxicities. Our
pioneering Synthetic vRNA Immunotherapy Platform involves a highly
innovative, novel combination of RNA- and oncolytic virus-based
modalities designed to realize the potential of RNA medicines for
cancer. Our lead IV-administered Synthetic vRNA Immunotherapy
clinical candidates, ONCR-021 and ONCR-788, are both currently in
IND-enabling studies.
Please visit www.oncorus.com to learn more.
Investor Contact:Stern Investor
RelationsJulie SeidelJulie.seidel@sternir.com
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From Apr 2024 to May 2024
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From May 2023 to May 2024